From the Journals
Latest News
Already-available drug could help treat type 1 diabetes
DFMO inhibits the polyamine biosynthesis pathway, which plays a role in the inflammatory responses in autoimmune diseases.
From the Journals
Use the stool! Fecal microbiota transplants help kids with diarrheal infection
“When we think about the microbiome it makes sense to target kids, because they’re more apt to respond to these therapies. I worry that somebody...
From the Journals
Study confirms small blood cancer risk from CT scans
New research suggests that radiation exposure from CT scans heightens the risk of blood cancer in people under age 22.
Latest News
AAD updates guidelines for managing AD with phototherapy and systemic therapies
The work group recommended the inclusion of active comparator arms in randomized, controlled trials as new systemic therapies continue to be...
From the Journals
Long COVID and mental illness: New guidance
“Long COVID is real, and mental health conditions do not cause long COVID.”
From the Journals
Sensory comeback: New findings show the path to smell and taste recovery after COVID
“... There are still people suffering from it. ... It really has a significant psychological impact.”
Latest News
Review estimates acne risk with JAK inhibitor therapy
Acne has been reported to be an adverse effect of JAK inhibitors, but not much is known about how common acne is overall.
From the Journals
Studies address primary care oral health screening and prevention for children
In one paper, the United States Preventive Services Task Force finds there’s not enough evidence for routine oral health screening in primary care...
Latest News
Medicare 2024 base rate cut triggers calls for pay overhaul
The pay cuts come as costs of providing health care are expected to rise as much as 4.6% in 2024.
From the Journals
Nasal ventilation function may factor into children’s OSA
Corticosteroid treatment was associated with improvements in nasal resistance and acoustic rhinometry in children with obstructive sleep apnea...
From the Journals
Dupilumab-associated lymphoid reactions require caution
In cases involving unexpected responses or atypical presentations, clinicians must have a low threshold for stopping dupilumab.